Metropolitan Life Insurance CO Phathom Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$10.26 - $15.7 $4,565 - $6,986	445 Added 32.41%	1,818 $18,000
Q1 2023 May 15, 2023	SELL	$6.19 - $12.36 $179 - $358	-29 Reduced 2.07%	1,373 $9,000
Q4 2022 Jun 14, 2023	BUY	$9.18 - $11.53 $266 - $334	29 Added 2.11%	1,402 $15.7 Million
Q3 2022 Jun 14, 2023	BUY	$6.46 - $12.11 $187 - $351	29 Added 2.11%	1,402 $15.5 Million
Q2 2022 Jun 20, 2023	BUY	$6.2 - $15.5 $179 - $449	29 Added 2.11%	1,402 $11,000
Q1 2022 Jun 20, 2023	BUY	$11.55 - $20.06 $334 - $581	29 Added 2.11%	1,402 $19,000
Q1 2022 Mar 30, 2023	SELL	$11.55 - $20.06 $52,437 - $91,072	-4,540 Reduced 76.41%	1,402 $19,000
Q1 2022 May 12, 2022	SELL	$11.55 - $20.06 $52,437 - $91,072	-4,540 Reduced 76.41%	1,402 $19,000
Q4 2021 Jun 21, 2023	BUY	$17.83 - $33.15 $81,465 - $151,462	4,569 Added 332.77%	5,942 $116,000
Q3 2021 Jun 21, 2023	BUY	$30.69 - $36.83 $140,222 - $168,276	4,569 Added 332.77%	5,942 $190,000
Q2 2021 Jun 21, 2023	BUY	$32.66 - $39.87 $149,223 - $182,166	4,569 Added 332.77%	5,942 $201,000
Q2 2021 Mar 30, 2023	BUY	$32.66 - $39.87 $76,914 - $93,893	2,355 Added 65.65%	5,942 $201,000
Q2 2021 Aug 16, 2021	BUY	$32.66 - $39.87 $193,935 - $236,748	5,938 Added 148450.0%	5,942 $201,000
Q1 2021 Jun 26, 2023	BUY	$33.86 - $48.68 $74,966 - $107,777	2,214 Added 161.25%	3,587 $135 Million
Q1 2021 May 14, 2021	SELL	$33.86 - $48.68 $121,320 - $174,420	-3,583 Reduced 99.89%	4 $135,000
Q4 2020 Jun 22, 2023	BUY	$33.22 - $50.26 $73,549 - $111,275	2,214 Added 161.25%	3,587 $119,000
Q3 2020 Jun 26, 2023	BUY	$29.24 - $40.19 $64,737 - $88,980	2,214 Added 161.25%	3,587 $131,000
Q2 2020 Jun 26, 2023	BUY	$25.06 - $54.6 $55,482 - $120,884	2,214 Added 161.25%	3,587 $118,000
Q1 2020 Jul 12, 2023	BUY	$24.65 - $42.83 $54,575 - $94,825	2,214 Added 161.25%	3,587 $92,000
Q1 2020 Mar 30, 2023	BUY	$24.65 - $42.83 $53,860 - $93,583	2,185 Added 155.85%	3,587 $92,000
Q1 2020 May 15, 2020	BUY	$24.65 - $42.83 $88,419 - $153,631	3,587 New	3,587 $93,000

Others Institutions Holding PHAT

# of Institutions

143

Shares Held

74.8M

Call Options Held

42.3K

Put Options Held

45.7K

Frazier Life Sciences Management, L.P. Menlo Park, CA

10.1M
Shares

$70.3 Million
9.84% of portfolio
Medicxi Ventures Management (Jersey) LTD

7.46M
Shares

$51.9 Million
13.31% of portfolio
Jennison Associates LLC

7.06M
Shares

$49.1 Million
0.04% of portfolio
Invesco Ltd. Atlanta, GA

4.1M
Shares

$28.5 Million
0.01% of portfolio
Carlyle Group Inc. Washington, DC

3.5M
Shares

$24.3 Million
9.52% of portfolio

View Full List

About Phathom Pharmaceuticals, Inc.

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $272M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

More about PHAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account